Renovacor Announces the Appointment of Marc Semigran, M.D., as Chief Medical Officer
PHILADELPHIA and BOSTON, June 02, 2021 (GLOBE NEWSWIRE) -- Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology...
Search for Articles
Jun 2, 2021
May 20, 2021
HAYA Therapeutics Completes CHF 18 Million Seed Financing To Advance Anti-fibrotic Therapies Targeting Long Non-coding RNAs
Lausanne, Switzerland, 20 May 2021 -- HAYA Therapeutics, SA, a company developing precision medicines that...
Mar 23, 2021
Renovacor, Inc. to Merge with Chardan Healthcare Acquisition 2 Corp.
PHILADELPHIA and NEW YORK, March 23, 2021 /PRNewswire/ -- Renovacor, Inc. ("Renovacor" or the "Company"), an...
Dec 7, 2020
Basking Biosciences, Inc. Completes $5.4M Seed Financing
December 07, 2020 08:30 AM Eastern Standard Time COLUMBUS, Ohio--(BUSINESS WIRE)--Basking Biosciences, Inc. (Basking), a...
Nov 30, 2020
Vectorious’ in-heart microcomputer is granted FDA breakthrough designation
November 30, 2020. Vectorious Medical Technologies today announced that the FDA has granted breakthrough device...